Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China flag China · Delayed Price · Currency is CNY
22.97
-0.30 (-1.29%)
Mar 26, 2026, 11:30 AM CST

SHA:600332 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
14,94018,27321,30922,50022,377
Short-Term Investments
8,8614,446729.162,117-
Trading Asset Securities
4-456.87-
Cash & Short-Term Investments
23,80522,71922,04224,67322,377
Cash Growth
4.78%3.07%-10.66%10.26%14.61%
Accounts Receivable
20,94019,45619,59819,16817,211
Other Receivables
1,186993.65882.35920.511,276
Receivables
22,12620,44920,48020,08818,486
Inventory
13,13812,81211,50710,67210,438
Other Current Assets
2,4491,7821,9551,6311,510
Total Current Assets
61,51857,76255,98457,06452,811
Property, Plant & Equipment
8,3657,9397,5166,5705,684
Long-Term Investments
8,79310,1469,4525,8972,891
Goodwill
834.09830.85829.47829.47829.47
Other Intangible Assets
3,1812,8292,8862,5852,582
Long-Term Deferred Tax Assets
1,2861,2101,164865.34794.23
Long-Term Deferred Charges
162.47558.49499.77407.47143.05
Other Long-Term Assets
370.9407.77256.22446.54382.46
Total Assets
84,51181,68478,58774,66566,118
Accounts Payable
17,57116,32015,68614,96114,733
Accrued Expenses
3,5693,6733,6513,4843,478
Short-Term Debt
9,8609,1237,7999,1468,428
Current Portion of Long-Term Debt
2,0271,33236.45498.5830.03
Current Portion of Leases
185.2190.57213.38208.15215.77
Current Income Taxes Payable
170.9118.4249.26237143.41
Current Unearned Revenue
2,8335,0725,4305,6442,740
Other Current Liabilities
2,9093,0883,1703,2162,485
Total Current Liabilities
39,12538,91636,23537,39532,254
Long-Term Debt
3,1742,8063,3241,639752.81
Long-Term Leases
371.47445.72578.19545.84497.7
Long-Term Unearned Revenue
1,0421,0021,001930.93826.86
Pension & Post-Retirement Benefits
0.290.30.290.320.3
Long-Term Deferred Tax Liabilities
599.37625.56639.53394.59331.73
Other Long-Term Liabilities
116.74119.31130.6121.45127.87
Total Liabilities
44,42843,91441,90941,02734,791
Common Stock
1,6261,6261,6261,6261,626
Additional Paid-In Capital
10,32410,11410,10610,1069,957
Retained Earnings
25,86124,17923,21220,34717,497
Comprehensive Income & Other
-22.6-13.84-24.34-12.9-17.48
Total Common Equity
37,78835,90534,91932,06529,062
Minority Interest
2,2951,8651,7591,5732,264
Shareholders' Equity
40,08337,77036,67833,63831,327
Total Liabilities & Equity
84,51181,68478,58774,66566,118
Total Debt
15,61713,89711,95112,0389,924
Net Cash (Debt)
8,1888,82310,09112,63512,453
Net Cash Growth
-7.20%-12.57%-20.14%1.47%24.99%
Net Cash Per Share
5.045.436.217.777.66
Filing Date Shares Outstanding
1,6261,6261,6261,6261,626
Total Common Shares Outstanding
1,6261,6261,6261,6261,626
Working Capital
22,39418,84719,74819,66920,557
Book Value Per Share
23.2422.0821.4819.7217.88
Tangible Book Value
33,77332,24531,20328,65125,650
Tangible Book Value Per Share
20.7719.8319.1917.6215.78
Buildings
6,4645,2134,3283,6303,317
Machinery
5,5215,1064,4164,0253,582
Construction In Progress
1,1501,8462,4052,1081,564
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.